Xtant Medical Holdings, Inc.
XTNT- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001453593
No open-market purchases or sales by Xtant Medical Holdings, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $33.8M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 1:12 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Mar 31, 2026 | Mar 6, 2025 | Apr 1, 2024 | Mar 7, 2023 | Mar 8, 2022 |
| Revenue | $133.9M | $117.3M | $91.3M | $58.0M | $55.3M |
| Cost of revenue | $49.7M | $49.1M | $35.8M | $25.8M | $22.8M |
| Gross profit | $84.3M | $68.2M | $55.5M | $32.1M | $32.5M |
| Operating expenses | $77.0M | $80.3M | $65.6M | $38.9M | $36.3M |
| Research and development | $2.10M | $2.38M | $1.34M | $915.0K | $870.0K |
| Selling, general and administrative | $29.4M | $28.7M | $25.9M | $15.5M | $14.4M |
| Operating income | $7.28M | -$12.1M | -$10.2M | -$6.75M | -$3.85M |
| Interest expense | $3.67M | $4.16M | $2.94M | $1.69M | $995.0K |
| Income tax | $2.03M | $187.0K | -$1.70M | $69.0K | – |
| Net income | $4.97M | -$16.4M | $660.0K | -$8.48M | -$4.85M |
| EPS, basic | $0.04 | $-0.12 | $0.01 | $-0.09 | $-0.06 |
| EPS, diluted | $0.03 | $-0.12 | $0.01 | $-0.09 | $-0.06 |
| Weighted shares, basic | 139.5M | 133.7M | 119.1M | 94.1M | 85.5M |
| Weighted shares, diluted | 150.0M | 133.7M | 126.8M | 94.1M | 85.5M |
| Margins and growth | |||||
| Gross margin | 62.9% | 58.2% | 60.8% | 55.4% | 58.8% |
| Operating margin | 5.4% | -10.3% | -11.1% | -11.7% | -7.0% |
| Net margin | 3.7% | -14.0% | 0.7% | -14.6% | -8.8% |
| Revenue growth, year over year | +14.2% | +28.4% | +57.5% | +4.9% | +3.6% |
| Net income growth, year over year | – | −2,592.3% | – | – | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Mar 31, 2026 | Mar 6, 2025 | Apr 1, 2024 | Mar 7, 2023 | Mar 8, 2022 |
| Cash and equivalents | $17.1M | $6.20M | $5.71M | $20.3M | $18.2M |
| Accounts receivable | $17.8M | $20.7M | $20.7M | $10.9M | $7.15M |
| Inventory | $30.3M | $38.6M | $36.9M | $17.3M | $17.9M |
| Total current assets | $78.2M | $67.1M | $64.9M | $49.3M | $44.3M |
| Property, plant and equipment | $6.20M | $10.1M | $8.69M | $5.79M | $5.21M |
| Goodwill | $6.07M | $7.30M | $7.30M | $3.21M | $3.21M |
| Intangible assets | $299.0K | $8.36M | $10.1M | $344.0K | $400.0K |
| Total assets | $94.1M | $93.8M | $92.6M | $60.2M | $54.7M |
| Accounts payable | $3.84M | $7.92M | $7.05M | $3.49M | $2.62M |
| Short-term debt | $3.50M | – | – | $2.33M | – |
| Total current liabilities | $29.5M | $28.6M | $23.0M | $15.2M | $11.1M |
| Long-term debt | $11.0M | $22.0M | $17.2M | $9.69M | $11.8M |
| Total liabilities | $43.2M | $50.9M | $41.3M | $26.1M | $23.8M |
| Shareholders' equity | $51.0M | $43.0M | $51.3M | $34.2M | $30.9M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Mar 31, 2026 | Mar 6, 2025 | Apr 1, 2024 | Mar 7, 2023 | Mar 8, 2022 |
| Operating cash flow | $12.5M | -$11.9M | -$9.52M | -$5.34M | $439.0K |
| Capital expenditures | $2.38M | $4.11M | $1.46M | $1.76M | $2.12M |
| Free cash flow | $10.2M | -$16.0M | -$11.0M | -$7.11M | -$1.68M |
| Depreciation and amortization | $5.22M | $4.22M | $3.17M | $1.29M | $1.33M |
| Stock-based compensation | $2.89M | $4.12M | $2.74M | $2.46M | $2.21M |
| Investing cash flow | $7.90M | -$3.73M | -$24.8M | -$1.56M | -$1.89M |
| Financing cash flow | -$9.57M | $16.1M | $19.7M | $9.02M | $17.5M |
| Net change in cash | $11.1M | $298.0K | -$14.6M | $2.12M | $16.0M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 2.2% | 3.5% | 3.0% | 4.3% | 4.0% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Aug 7, 2026 | 140.3M | +7.7% | SEC |
| May 8, 2026 | 140.3M | +0.7% | SEC |
| Mar 25, 2026 | 140.1M | +0.7% | SEC |
| Nov 7, 2025 | 140.0M | +0.7% | SEC |
| Aug 8, 2025 | 130.3M | 0.0% | SEC |
| May 9, 2025 | 139.3M | +7.0% | SEC |
| Mar 3, 2025 | 139.1M | +6.8% | SEC |
| Nov 7, 2024 | 139.0M | +6.8% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.